Home › Funds › PERCEPTIVE ADVISORS LLC › CORT
PERCEPTIVE ADVISORS LLC position in CORT
CORCEPT THERAPEUTICS INC · Health Care
PERCEPTIVE ADVISORS LLC reported holding 398,385 shares of CORT (CORCEPT THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$34.6M, representing 0.55% of its reported portfolio and ranking #40 among its reported holdings. PERCEPTIVE ADVISORS LLC has disclosed CORT holdings in 2 of the last 2 reported quarters, going back to Q1 2026.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How PERCEPTIVE ADVISORS LLC's CORT position evolved
PERCEPTIVE ADVISORS LLC first disclosed a stake in CORT in Q1 2026 at 50,000 shares (US$2.0M). The position peaked in Q2 2026 at 398,385 shares, worth US$34.6M. Across 2 filings, PERCEPTIVE ADVISORS LLC increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 398,385 shares valued at US$34.6M — an increase of 348,385 shares quarter over quarter.. Notable position changes include a 697% increase in Q2 2026 (shares rose 33% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2026 | 50.00K | $2.02M | New |
| Q2 2026 | 398.38K | $34.64M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About CORT and 13F data
CORT (CORCEPT THERAPEUTICS INC) is a Health Care company. 38 other funds we track also report a position in CORT — the largest reported positions include Renaissance Technologies (US$457.5M), Parallel Advisors, LLC (US$344.5M), TANG CAPITAL MANAGEMENT LLC (US$130.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding CORT
- Renaissance Technologies 5.26M sh · $457.50M · Q2 2026
- Parallel Advisors, LLC 3.96M sh · $344.51M · Q2 2026
- TANG CAPITAL MANAGEMENT LLC 1.50M sh · $130.43M · Q2 2026
- MPM BioImpact LLC 771.03K sh · $67.04M · Q2 2026
- EMERALD ADVISERS, LLC 748.33K sh · $65.07M · Q2 2026
- EMERALD MUTUAL FUND ADVISERS TRUST 464.90K sh · $40.42M · Q2 2026
More on PERCEPTIVE ADVISORS LLC
FAQ
How long has PERCEPTIVE ADVISORS LLC held CORT?
PERCEPTIVE ADVISORS LLC has disclosed CORT holdings in 2 of the last 2 reported quarters, going back to Q1 2026.
What is PERCEPTIVE ADVISORS LLC's current position in CORT?
As of Q2 2026, PERCEPTIVE ADVISORS LLC holds 398.38K shares of CORT (CORCEPT THERAPEUTICS INC), valued at $34.64M, representing 0.55% of its reported portfolio and ranking #40.
Has PERCEPTIVE ADVISORS LLC been buying or selling CORT?
In the latest 13F filing (Q2 2026), PERCEPTIVE ADVISORS LLC increased its position in CORT. The position peaked in Q2 2026 at 398.38K shares.
Which other funds hold CORT?
Other major institutional holders of CORT include Renaissance Technologies, Parallel Advisors, LLC, TANG CAPITAL MANAGEMENT LLC, among 38 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.